Fiona Taylor - Concepedia

Author

Fiona Taylor

Also Known As

F C TAYLOR, F C Taylor, F TAYLOR, F Taylor, F. C. TAYLOR, F. C. Taylor, F. Taylor, Fc Taylor, Fiona C Taylor, Fiona C. Taylor

176

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Adelphi Laboratory Center Bristol-Myers Squibb (United States)Adelphi Group (United Kingdom)German Center for Lung Research University of Liverpool

About

Fiona Taylor is an author at Adelphi Laboratory Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	2K
2	Health Sciences	6	6	610
3	Public Health	4	4	80
4	Nursing	2	2	109
5	Business	1	1	20

Fiona Taylor

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials Gianni D. Angelini, Fiona Taylor, Barnaby C Reeves, The Lancet Assisted CirculationBhacas 1Cardiac AnaesthesiaCardiopulmonary ResuscitationCardiovascular Disease	2002	569
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, The Lancet Oncology OncologyNeoadjuvant TherapyCheckmate 141Cancer ManagementClinical Trials	2017	417
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial David Cella, Viktor Grünwald, Paul Nathan, The Lancet Oncology Checkmate 025UrologyGenitourinary CancerMedicineCancer Treatment	2016	217
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial Martin Reck, Michael Schenker, Ki Hyeong Lee, European Journal of Cancer	2019	212
Depression — An independent predictor of early death in patients with advanced cancer Mari Lloyd‐Williams, Chris Shiels, Fiona Taylor, Journal of Affective Disorders Advanced CancerPsychopathologyPsychiatryMood SymptomEnd-of-life Care	2008	145
A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery Barnaby C Reeves, Gianni D. Angelini, A J Bryan, Health Technology Assessment	2004	143
Statin Therapy for Primary Prevention of Cardiovascular Disease Fiona Taylor, Mark D. Huffman, Shah Ebrahim JAMA	2013	141
A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer Mari Lloyd‐Williams, Mick Dennis, Fiona Taylor Palliative Medicine Palliative CarePsychological Co-morbiditiesAdvanced CancerCancer LiteracyPsychiatry	2004	128
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study Georgina V. Long, Victoria Atkinson, Paolo A. Ascierto, Annals of Oncology	2016	111
Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study Martin Reck, Fiona Taylor, John R. Penrod, Journal of Thoracic Oncology Checkmate 017OncologyHealth-related QualityCancer ManagementOutcomes Research	2017	106

Page 1